Your Cart ( 1 Item )

• Long-Term Safety and Efficacy of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of a 1-Year Open-Label Study
  January 2014 | Volume 13 | Issue 1 | Original Article | 56 | Copyright © January 2014
  Angela Moore MD,^a Steven Kempers MD,^b George Murakawa MD,^c Jonathan Weiss MD,^d Amanda Tauscher MD,^e Leonard Swinyer MD,^f Hong Liu MSc,^g and Matthew Leoni MD^g on behalf of the Brimonidine LTS Study Group
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs